Navigation Links
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Date:11/14/2007

Multi-national study compared FORTEO and the currently approved therapy

Fosamax for the treatment of Glucocorticoid-Induced Osteoporosis

INDIANAPOLIS, Nov. 14 /PRNewswire-FirstCall/ -- New data, published today in The New England Journal of Medicine, showed that in patients with glucocorticoid-induced osteoporosis FORTEO(R) (PTH 1-34, teriparatide [rDNA origin] injection) significantly increased lumbar spine bone mineral density (BMD) from baseline (8.2 percent) compared to Fosamax(R) (alendronate, 3.9 percent) at 18 months of therapy.(1)

In this head-to-head comparator study, the increase in lumbar spine BMD was significantly greater in patients receiving teriparatide compared with alendronate at 6, 12, and 18 months of treatment (p < 0.001 at all time points).(1)

Glucocorticoid therapy is the most common cause of secondary osteoporosis,(2) leading to bone loss and an increased risk for fracture. Data indicate that glucocorticoids are used by up to three out of every 100 adults (3 percent) over age 50,(3) and up to 50 percent of individuals on chronic glucocorticoid therapy will eventually have an osteoporotic fracture.(4) Glucocorticoids are prescribed to treat many conditions, including rheumatoid arthritis, chronic obstructive pulmonary disease and inflammatory bowel disease.(4,5)

"Currently, there is a lack of variety in treatment choices for patients receiving chronic glucocorticoid medication who are at high risk for fractures," said lead investigator Kenneth G. Saag, M.D., MSc, professor of medicine and epidemiology at the University of Alabama in Birmingham. "These data are important because they show that teriparatide may have the potential to be a viable therapeutic option in the future for people with this disease."

Teriparatide is not indicated for the treatment of glucocorticoid-induced osteoporosis. Teriparatide is the first osteoporosis therapy approved by the U.S. Food and Drug Administration (FDA) and the
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
2. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
3. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
4. Superbug Outbreak Calls for Immediate Increased Attention on Infection Control
5. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
6. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
7. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
8. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...RNewswire/ -- Axentis Pharma AG has,initiated a cl...lerability,of a new therapeutic formulation for th...c fibrosis patients. The new formulation allows an...ectly to the site of,infection. The forthcoming tr... doses of the new drug. Initial results are expect...
(Date:9/4/2008)...cation for Targeted Therapies That En...TON BEACH, Calif., and AMSTERDAM, Netherlands, Sep...lecular cancer diagnostics,today announced the la...,allows physicians to quantitatively determine the...ER), progesterone receptor (PR) and Human Epiderma...
(Date:9/3/2008)...g Children Studied. Wrong,Conclusions Reached., N...ters for Disease,Control and Prevention (CDC) stud...he MMR vaccine and autism. The National Autism Ass...pel the growing public concern over a,vaccine-auti...ing design,and methodology., For years, parents h...
(Date:9/3/2008)...chronically infected Hepatitis C,patients strongly... in 2008, - Study is the first to show a statist...effect of therapeutic Hepatitis C vaccination, -...a second generation, vaccine formulated with Inte... activation, VIENNA, Austr...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2CDC Misses Target With Flawed MMR/Autism Study 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4New approach builds better proteins inside a computer 863 1New approach builds better proteins inside a computer 863 2New approach builds better proteins inside a computer 863 3New approach builds better proteins inside a computer 863 4Changing the global dietary environment 861 1Changing the global dietary environment 861 2Deadlines for 2007 National Soybean Rust Symposium fast approaching 859 1Deadlines for 2007 National Soybean Rust Symposium fast approaching 859 2Tolerance to inhalants may be caused by changes in gene expression 857 1Tolerance to inhalants may be caused by changes in gene expression 857 2
...7 - EPIX,Pharmaceuticals, Inc. (NASDAQ: EPIX) toda...X-00023, a novel long-acting 5-HT1A agonist,was f...l New,Clinical Drug Evaluation Unit (NCDEU) Meetin... by the National Institutes of,Health and the Amer...presentation highlighted data from a randomized,d...
... Prolexys,Pharmaceuticals and announced today a pu...ve small molecule anti-tumor agent,erastin. Prole...omics technology to understand the mechanism of ac...he June 14, 2007 issue,of the journal Nature revea...endent anion channels (VDACs) -- a novel target fo...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...ly hurt in a farm accident, claimed a chance for s... The 16 year old teenage boy had suffered grave in... helicopter. Insp Roger McConnell, who accompanied...n't want to take all the credit, because the fire ...
...arize and improve collaboration regarding the emer...se, more specifically bird flu//, a training progr...scenario involving transfer of a suspected case of...er was simulated. The Baptist Hospital and the Qu...
...eat promise for new treatments for many conditions... types of adult tissue//. But the human embryo ste... scientists believe the human testicle may provide...or stem cell research. A German team has describ...
...g sensitive to noise, and do not like it much! Acc...noisy surroundings// may face an increased risk of... revealed that the chances of urban middle-aged ad...and amidst a lot of din, stood a 46 percent chance...
Other Medicine News:Health News:Human Testicular Cells Would Help In Stem Cell Research 2
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
Medicine Products: